Robert B. Bazemore, President & CEO at Epizyme, Inc. (EPZM), sold 9,546 shares at $16.15 ($154K) on 2020-06-26, disclosed to the SEC on 2020-06-30.
Open-market sale of $154k EPZM by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.15 | 4,773 | $77K | 50.0% |
| 2 | $16.15 | 4,773 | $77K | 50.0% |
| Total | $16.15 avg | 9,546 | $154K | 100% |
| Filing → |
| EPZM | SELL | 2021-02-05 | $44K | — | Filing → |
| EPZM | SELL | 2021-01-27 | $138K | — | Filing → |
| EPZM | SELL | 2020-06-22 | $220K | — | Filing → |